JAMES C YAO to Dacarbazine
This is a "connection" page, showing publications JAMES C YAO has written about Dacarbazine.
Connection Strength
0.069
-
Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211). J Clin Oncol. 2023 03 01; 41(7):1359-1369.
Score: 0.044
-
A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers. BMC Cancer. 2014 Aug 02; 14:561.
Score: 0.025